少免疫复合物肾小球肾炎诊断时低补体血症与晚期组织病理活动指数及高治疗抵抗概率相关
该回顾性研究纳入115例活检证实的少免疫复合物肾小球肾炎(PIGN)患者,按血清C3水平分组。20.9%患者C3降低,与更严重肾功能损害、急性透析需求及更低1年缓解率相关;低C3是治疗抵抗的独立预测因素。
要点
- PIGN诊断时20.9%患者存在低C3,与更严重肾功能损害和急性透析需求相关。
- 正常C3患者1年内85.7%对治疗有反应,低C3者仅58.3%。
- 低C3、少尿和高慢性化评分是治疗抵抗的独立预测因素。
核心结论
- 低血清C3是PIGN患者治疗抵抗的独立预测因素,且与诊断时更高的组织病理活动指数相关。
研究设计与样本
- 回顾性研究,纳入115例活检证实的少免疫复合物肾小球肾炎患者,按血清C3水平分组,评估组织病理活动与慢性化指数及治疗结局。
主要发现
- 20.9%患者血清C3降低,与更严重肾功能损害(P < 0.01)和更频繁需要急性透析(P < 0.01)相关。
- 1年内正常C3患者85.7%对治疗有反应,低C3患者仅58.3%(P = 0.001)。
- 治疗抵抗概率与低C3(P = 0.004)、高血清肌酐(P < 0.001)、急性透析需求(P < 0.001)和高组织病理慢性化评分(P < 0.01)相关。
- 晚期组织病理活动与更密集的间质白细胞浸润(P = 0.005)和更高概率发现血管壁纤维素样坏死(P = 0.02)相关。
- 治疗抵抗概率在低C3(OR = 6.47,95%CI 1.47-28.35,P = 0.013)、少尿(OR = 29.57,95%CI 4.74-184,P < 0.0001)和高慢性化评分(OR = 1.77,95%CI 1.23-2.54,P = 0.002)患者中更高。
临床怎么用
- 诊断PIGN时应检测血清C3,低C3提示更高治疗抵抗风险和更差肾脏预后。
- 对低C3的PIGN患者应加强监测并考虑更积极或替代治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Recent evidence suggests that complement activation is important in the pathogenesis of pauci-immune (PI) vasculitis. This is a retrospective investigation of the frequency of hypocomplementemia at pauci-immune glomerulonephritis (PIGN) diagnosis, in relation to vasculitic manifestations, renal histopathology, and treatment outcomes. METHODS: A total of 115 patients with biopsy-proven PIGN were categorized based on their serum complement C3 (sC3). Histopathology evaluation included activity and chronicity indexes. The primary outcome of interest was treatment resistance, defined as a progressive decline in kidney function, with persistently active urine sediment, leading to dialysis dependency or vasculitis-related death. RESULTS: In all, 20.9% of patients had low sC3 levels associated with more advanced renal impairment (P < 0.01), requiring acute dialysis (P < 0.01) more frequently compared to patients with normal sC3. Within 1 year, 85.7% of patients with normal sC3 responded to therapy, versus 58.3% of those with low sC3 (P = 0.001). The probability of treatment resistance was strongly associated with low sC3 (P = 0.004), high serum creatinine (P < 0.001), acute dialysis requirement (P < 0.001), and high histopathological score of chronicity (P < 0.01). Advanced histopathological activity was related to more intense interstitial leukocyte infiltration (P = 0.005) and higher likelihood of fibrinoid necrosis documentation in a vessel wall (P = 0.02). The probability of treatment resistance was higher in patients with low sC3 (odds ratio [OR] = 6.47, 95% confidence interval [CI] 1.47-28.35, P = 0.013), oliguria (OR = 29.57, 95% CI = 4.74-184, P < 0.0001), and high chronicity score (OR = 1.77, 95% CI = 1.23-2.54, P = 0.002). CONCLUSION: Low sC3 is emerging as an independent predictor of treatment resistance in patients with PIGN associated with higher index of histopathological activity at diagnosis compared to normal sC3.
引用
- Lionaki S, Marinaki S, Liapis G, et al. Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated With Advanced Histopathological Activity Index and High Probability of Treatment Resistance. Kidney Int Rep. 2021. PMID: 34514203. doi:10.1016/j.ekir.2021.05.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。